IL33 and colorectal carcinoma: Overall, these data suggest that IL-33 enhances the sensitivity of CRC cells to 5-FU in a T cell-dependent manner, and that IL-33-mediated T cell responses skew towards the antitumoral Th1-biased axis, but not the Th2 cytokine-associated immune responses.